FDA Clears Dual-Head SPECT/CT System with Deep Learning Image Reconstruction
The combination of the Aurora SPECT/CT system with AI-enabled Clarify DL image reconstruction reportedly offers the potential of enhanced image quality and streamlined workflows in nuclear medicine.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the Aurora single photon emission computed tomography/computed tomography (SPECT/CT) system and Clarify DL deep learning image reconstruction.
GE HealthCare, the developer of the dual-head Aurora SPECT/CT system, said the device offers the following key benefits:
The newly FDA-cleared dual-head Aurora SPECT/CT system has a 40 mm detector, which offers twice the coverage of CTs from other hybrid systems, and 128-slice capabilities across imaging applications in neurology, cardiology, and oncology, according to GE HealthCare, the developer of the Aurora SPECT/CT platform. (Image courtesy of GE HealthCare.)
• a 40 mm detector offering twice the coverage of CTs from other hybrid systems;
• 128-slice capabilities across imaging applications in neurology, cardiology, and oncology; and
• a 5/8-inch crystal Nal detector, which allows use of a variety of radiopharmaceuticals including theranostics.
Through advanced deep learning technology, GE HealthCare maintained that Clarity DL image reconstruction bolsters quality for bone SPECT imaging without the need for increased radiation dosing or scan time.
“Aurora’s seamless integration of SPECT and CT components will allow us to perform comprehensive, high-quality diagnostic exams in a single session, while its support of Clarify DL deep-learning image reconstruction enables enhanced image quality performance,” noted Donna Plecha, M.D., chair of the Department of Radiology at University Hospitals Cleveland Medical Center, and a professor of radiology at the Case Western Reserve University School of Medicine in Cleveland.
Recent Videos
Related Content
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025Article
In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025Article
In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025Article
In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
